NASDAQ: CLPTClearpoint Neuro Inc Stock Ownership - Who owns Clearpoint Neuro?
Insider buying vs selling
Have Clearpoint Neuro Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Danilo Dalessandro | Chief Financial Officer | 2025-11-21 | 3,555 | $8.10 | $28.80kBuy |
| Mazin Sabra | Chief Operating Officer | 2025-10-10 | 7,480 | $26.11 | $195.30kSell |
| Joseph Burnett | CEO and President | 2025-10-10 | 6,599 | $27.64 | $182.40kSell |
| Joseph Burnett | CEO and President | 2025-10-10 | 1,981 | $28.64 | $56.74kSell |
| Joseph Burnett | CEO and President | 2025-10-10 | 300 | $29.21 | $8.76kSell |
| Joseph Burnett | CEO and President | 2025-10-10 | 17,583 | $26.51 | $466.13kSell |
| Pascal E. R. Girin | Director | 2025-10-01 | 315 | $21.79 | $6.86kBuy |
| R. John Fletcher | Director | 2025-10-01 | 265 | $21.79 | $5.77kBuy |
| Timothy T. Richards | Director | 2025-10-01 | 555 | $21.79 | $12.09kBuy |
| R. John Fletcher | Director | 2025-07-01 | 484 | $11.94 | $5.78kBuy |
CLPT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CLPT insiders and whales buy or sell their stock.
CLPT Shareholders
What type of owners hold Clearpoint Neuro Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Bruce C. Conway | 14.07% | 4,000,509 | $57.97M | Insider |
| Blackrock Inc | 6.55% | 1,861,746 | $26.98M | Institution |
| Vanguard Group Inc | 5.27% | 1,497,637 | $21.70M | Institution |
| Geode Capital Management LLC | 2.31% | 656,397 | $9.51M | Institution |
| Michael Pietrangelo | 1.76% | 499,891 | $7.24M | Insider |
| State Street Corp | 1.70% | 482,650 | $6.99M | Institution |
| Voyager Therapeutics Inc | 1.41% | 400,000 | $5.80M | Insider |
| James K. Malernee Jr. | 1.33% | 378,722 | $5.49M | Insider |
| Ubs Group Ag | 1.27% | 360,705 | $5.23M | Institution |
| Brown Advisory Inc | 1.16% | 330,727 | $4.79M | Institution |
CLPT vs Medical Device Stocks
Clearpoint Neuro Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.